Nonin Medical Inc kicked off the new year with the release of its WristOx2, Model 3150, a wrist-worn pulse oximeter that monitors blood-oxygen saturation levels and pulse rate in patients undergoing ambulatory monitoring to screen for sleep disorders such as obstructive sleep apnea.
Engineered with Nonin’s PureSAT SpO2 technology, the WristOx2, Model 3150 is proven clinically accurate in the widest range of clinical settings and challenging patient conditions such as motion and low perfusion, according to information from the company. Featuring Bluetooth wireless technology, a new ergonomic design, and larger screen size, the WristOx2, Model 3150 is designed to increase patient comfort and ease of use.
"Nonin Medical’s goal is to help clinicians improve patient outcomes through reliable noninvasive monitoring solutions," said Kevin McGowan, vice president of sales for Nonin Medical. "The WristOx2, Model 3150 delivers proven accuracy in the widest range of patient populations and clinical settings. For health care professionals, the simple design enables increased ambulatory monitoring capabilities while the advanced technology ensures reliable data collection on the first try."
The WristOx2, Model 3150 is built on a single platform to serve both stand-alone and OEM applications—replacing the WristOx 3100 and 4100 modules. Performance upgrades to the WristOx2, Model 3150 include increased connectivity with USB and Continua-certified Bluetooth technologies for real-time data transmission, enhanced nonvolatile memory to ensure data won’t be lost during battery change, and up to 48 hours of battery life on two AAA batteries. Additionally, the WristOx2, Model 3150 comes standard with an exclusive new soft sensor for improved patient comfort during long-term use.
